MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway
{{output}}
Tumor metabolism is characterized by dynamic plasticity, but there is a lack of appropriate tools to detect metabolic changes across different tumor stages, limiting the application of metabolism-targeted therapies. Our study introduces a noninvasive liquid bi... ...